Evolve Global Healthcare Enhanced Yield Fund Hedged Units (LIFE.TO) ETF Analysis

Fund Overview

Evolve Global Healthcare Enhanced Yield Fund Hedged Units (LIFE.TO) is an exchange-traded fund. Evolve Funds Group Inc is the fund family on file. The inception date on file is November 26, 2019. Annual costs run at an expense ratio of 0.45%. On a CA$10,000 position that is CA$45.00 a year.

The largest positions on file are Bristol-Myers Squibb Co (BMY), Thermo Fisher Scientific Inc (TMO), and Abbott Laboratories (ABT). Bristol-Myers Squibb Co alone accounts for 5.54% of the portfolio. The ten largest positions together make up 51.84% of the fund.

Performance Analysis

The most recent close on file for LIFE.TO is CA$18.16, dated September 4, 2026. The trailing one-year price return is +10.93%. Measured over 5 years, that is +4.32% a year compounded. The trailing distribution yield is 12.95%.

The strongest complete calendar year on file is 2019 at +25.02%; the weakest is 2022 at +0.41%. Of the 7 complete calendar years on file, 7 finished higher. 2026 is still running; the price is +1.44% year to date.

Price & Risk Profile

Annualized volatility over the trailing 8 years is 15.27%. The reported beta is 0.91. The 52-week range on file runs from CA$16.40 to CA$20.22. The latest close sits 10.73% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.